Combined Use of Ibandronate and Eldecalcitol in Postmenopausal Japanese Women with Osteoporosis
Purpose To evaluate the effect of combined use of ibandronate and eldecalcitol for 6 to 12 months on bone mineral density (BMD) and bone strength of the proximal femur in postmenopausal Japanese women with osteoporosis. Methods BMD and bone strength of the proximal femur were evaluated in 78 postmen...
Main Authors: | Junichi Takada, Hiroshi Wada, Kousuke Iba, Kouichi Sasaki, Takayuki Dohke, Kumiko Kanaya, Takashi Yoshizaki, Toshihiko Yamashita |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2016-12-01
|
Series: | Journal of Orthopaedic Surgery |
Online Access: | https://doi.org/10.1177/1602400318 |
Similar Items
-
Effects of eldecalcitol and ibandronate on secondary osteoporosis and muscle wasting in rats with adjuvant-induced arthritis
by: Yuichi Ono, et al.
Published: (2018-12-01) -
Eldecalcitol for the treatment of osteoporosis
by: Noguchi Y, et al.
Published: (2013-09-01) -
Comparison of effectiveness and safety of ibandronate and minodronate combined with eldecalcitol in primary osteoporosis of women: A 1-year follow-up study
by: Mizue Tanaka, et al.
Published: (2017-03-01) -
Quarterly intravenous injection of ibandronate to treat osteoporosis in postmenopausal women
by: Philip Sambrook
Published: (2007-04-01) -
Efficiency of Ibandronate in Monotherapy and in Combination with Alfacalcidol in Women with Postmenopausal Osteoporosis
by: S.I. Ismailov, et al.
Published: (2016-09-01)